FCS Drives Cancer Care Forward Through Expert Collaboration and Innovative Dialogue at Exclusive Event

Former Olympian and Breast Cancer Survivor to Give Keynote Address

Fort Myers, Fla., February 27, 2025 — Florida Cancer Specialists & Research Institute, LLC  is again partnering with Research to Practice® for the Fourth Annual National General Medical Oncology Summit in Miami. The one-of-a-kind educational experience will provide insights from some of the leading experts in the field through a dynamic mix of presentations, engaging moderated panel discussions and Q&A sessions focused on significant new datasets, emerging treatment strategies and key interdisciplinary management considerations.

“This unique event is tailored specifically to meet the distinct needs of our medical oncologists and frontline cancer care professionals,” said FCS President & Managing Physician Lucio N. Gordan, MD. “The distinguished faculty of clinical researchers and practitioners presenting cutting-edge findings and key insights are essential for improving both clinical and operational decision-making – a combination that aligns perfectly with the needs of our providers. The ultimate goal is to ensure patients receive the highest quality, personalized care and achieve the best possible outcomes.”

The following FCS medical oncologists and hematologists will moderate didactic presentations and discussions on a variety of oncology topics:

• Maria Regina Flores, MD – Multiple Myeloma
• Sunil Gandhi, MD, FACP – Neuroendocrine Tumors and Prostate Cancer
• Lucio N. Gordan, MD, FCS president & managing physician – Immunotherapy and Other Nontargeted Approaches for non-small cell lung cancer and Pancreatic Cancer
• Maen Hussein, MD, FCS medical director of value-based care—Her2/Triple-negative/Localized Breast Cancer and Systemic Mastocytosis/Myelofibrosis
• Mary Li, MD, PhD – EGFR Mutation-positive Non-small Cell Lung Cancer
• Vikas Malhotra, MD – Non-Hodgkin Lymphoma
• Bradley Monk, MD, FCS medical director, late-phase clinical research – Gynecologic Cancer
• Anjan Patel, MD – Colorectal Cancer
• Frank Rodriguez, MD – Sarcoma and other Connective Tissue Neoplasms
• Savan Shah, MD – Chronic Lymphocytic Leukemia
• Sumithra Vattigunta-Gopal, MD, FACP– Bladder Cancer and Hepatocellular Cancer
• Faye Yin, MD – Biliary Tract Cancers and Gastroesophageal Cancer

Four-time Olympian high jumper and breast cancer survivor, Chaunté Lowe, the keynote speaker for an FCS-exclusive session, will share her unique perspective on how oncologists and care teams can ensure patients feel heard, understood and actively involved in their care. Lowe will highlight the profound impact the compassionate, patient-centered care she received from FCS in 2019 contributed to her transformative journey of healing.

During a fireside chat moderated by FCS Assistant Managing Physician David Wenk, MD and  FCS Chief Executive Officer Nathan H. Walcker, Lowe will reflect on the lessons providers and care teams can take from her training as a high-performance athlete to foster resilience and create a seamless experience for patients.

Lowe continues to inspire and empower cancer patients and their care providers in worldwide appearances. In November 2024, she joined FCS clinicians and leaders for a Biden Cancer Moonshot event at the White House to discuss the vital and positive impact of navigation services for cancer patients.

FCS is hosting additional opportunities for FCS physicians and clinicians to share perspectives and network with colleagues and future oncologists throughout the course of the weekend.

Nathan H. Walcker, FCS Chief Executive Officer, said,  “This premier event is gaining national recognition for fostering impactful collaboration and innovation that is enhancing oncology care and the patient experience in community settings across the country.”

Founded and led by medical oncologist Neil Love, MD, Research to Practice® has provided meaningful, relevant and unbiased educational perspectives for more than 30 years to meet the needs of oncology clinicians and positively impact the care of patients with cancer.